Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Interest Receivables Change in Net Loans Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Growth Metrics

Others

Elite Health Systems (EHSI) Capital Expenditures (2016 - 2025)

Elite Health Systems' Capital Expenditures history spans 6 years, with the latest figure at $17000.0 for Q4 2025.

Quarterly results put Capital Expenditures at $17000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $1.0 million (changed N/A YoY), and the annual figure for FY2025 was $1.0 million, changed.
Capital Expenditures for Q4 2025 was $17000.0 at Elite Health Systems, down from $225000.0 in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $526000.0 in Q1 2025 to a low of $17000.0 in Q4 2025.